Literature DB >> 29904301

Flecainide toxicity in renal failure.

Rogin Subedi1, Ryan K Dean1, Arbind Chaudhary2, Tamas Szombathy2.   

Abstract

Flecainide, a class Ic antiarrhythmic, is used for the prevention of paroxysmal supraventricular tachycardia, paroxysmal atrial fibrillation/flutter, and sustained ventricular tachycardia. Flecainide is primarily metabolized by the liver and to a lesser extent (30%) is excreted unchanged in the kidney. We present a case of flecainide toxicity in the setting of renal impairment that was successfully treated with intravenous sodium bicarbonate.

Entities:  

Keywords:  Flecainide toxicity; renal failure; ventricular tachycardia

Year:  2018        PMID： 29904301      PMCID： PMC5997054          DOI： 10.1080/08998280.2018.1463042

Source DB:  PubMed          Journal:  Proc (Bayl Univ Med Cent)        ISSN： 0899-8280


  17 in total

Review 1.  2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society.

Authors:  Craig T January; L Samuel Wann; Joseph S Alpert; Hugh Calkins; Joaquin E Cigarroa; Joseph C Cleveland; Jamie B Conti; Patrick T Ellinor; Michael D Ezekowitz; Michael E Field; Katherine T Murray; Ralph L Sacco; William G Stevenson; Patrick J Tchou; Cynthia M Tracy; Clyde W Yancy
Journal:  J Am Coll Cardiol       Date:  2014-03-28       Impact factor: 24.094

Review 2.  The experimental basis for the choice of an anti-arrhythmic drug.

Authors:  E M Vaughan Williams
Journal:  Adv Cardiol       Date:  1970

Review 3.  Drug therapy. Flecainide.

Authors:  D M Roden; R L Woosley
Journal:  N Engl J Med       Date:  1986-07-03       Impact factor: 91.245

4.  Life-threatening flecainide toxicity. A pharmacodynamic approach.

Authors:  B R Winkelmann; H Leinberger
Journal:  Ann Intern Med       Date:  1987-06       Impact factor: 25.391

5.  ECG lead aVR versus QRS interval in predicting seizures and arrhythmias in acute tricyclic antidepressant toxicity.

Authors:  E L Liebelt; P D Francis; A D Woolf
Journal:  Ann Emerg Med       Date:  1995-08       Impact factor: 5.721

Review 6.  Intravenous lipid emulsion in clinical toxicology.

Authors:  Leelach Rothschild; Sarah Bern; Sarah Oswald; Guy Weinberg
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2010-10-05       Impact factor: 2.953

7.  A life-threatening flecainide overdose treated with intravenous fat emulsion.

Authors:  Heather Ellsworth; Samuel J Stellpflug; Jon B Cole; Joseph A Dolan; Carson R Harris
Journal:  Pacing Clin Electrophysiol       Date:  2012-08-08       Impact factor: 1.976

8.  Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial.

Authors:  D S Echt; P R Liebson; L B Mitchell; R W Peters; D Obias-Manno; A H Barker; D Arensberg; A Baker; L Friedman; H L Greene
Journal:  N Engl J Med       Date:  1991-03-21       Impact factor: 91.245

9.  Pharmacokinetics of flecainide acetate in patients with severe renal impairment.

Authors:  A J Williams; R L McQuinn; J Walls
Journal:  Clin Pharmacol Ther       Date:  1988-04       Impact factor: 6.875

Review 10.  Twenty-five years in the making: flecainide is safe and effective for the management of atrial fibrillation.

Authors:  Etienne Aliot; Alessandro Capucci; Harry J Crijns; Andreas Goette; Juan Tamargo
Journal:  Europace       Date:  2010-12-07       Impact factor: 5.214
View more
  3 in total

Review 1.  Management of tachyarrhythmias in pregnancy - A review.

Authors:  Priyanka Kugamoorthy; Danna A Spears
Journal:  Obstet Med       Date:  2020-04-20

2.  Cardiogenic Shock in a Hemodialyzed Patient on Flecainide: Treatment with Intravenous Fat Emulsion, Extracorporeal Cardiac Life Support, and CytoSorb® Hemoadsorption.

Authors:  Nicolas De Schryver; Philippe Hantson; Vincent Haufroid; Mélanie Dechamps
Journal:  Case Rep Cardiol       Date:  2019-07-24

3.  Flecainide toxicity in renal tubular acidosis type IV treated with extracorporeal membrane oxygenation.

Authors:  Salima Ahmed Bhimani; Sruti Rao; Holly Nadorlik; Elizabeth V Saarel; Peter F Aziz
Journal:  HeartRhythm Case Rep       Date:  2020-02-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.